Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Salestools Logo

Salestools

#1 AI-agent för säljteam och Go-to-Market-team. Sälj mer, snabbare, med mindre ansträngning.

Produkt

  • AI-säljagenter
  • Intentionsdata
  • Teknologidata
  • Besöksspårning
  • Medpilot
  • Social Försäljning

Lösningar

  • Kundservice
  • E-handel
  • SaaS
  • Företag
  • Småföretag

Resurser

  • Rapporten
  • Dokumentation
  • API-referens
  • Hjälpcenter
  • Blogg
  • Fallstudier
  • Webbinarier

Företag

  • Om oss
  • Karriärer
  • Press
  • Kontakt
  • Partners

Våra kontor

  • New York, HQ
  • Bukarest, AI-forskningslabb
  • Zug, Schweiz

© 2026 Salestools. Alla rättigheter förbehållna.

Datavillkor och SäkerhetSekretesspolicyAnvändarvillkorAcceptable Use
Alla system fungerar
Salestools LogoSalestools
Salestools AI-agenter
Lösningar
Resurser
Företag
Priser
Back to Reports
Fundraising

Span

Span Raises $231M in Series C

645 Harrison Street, San Francisco, CA 94107April 24, 20242 min read
Employees
300+

Span Raises $231M in Series C


Span has successfully raised $231M in a Series C at a $1B valuation led by 5335 Capital, Capricorn Investment Group, Montage Ventures, BlackRock.


Company Overview


Span is a Home Energy company headquartered in 645 Harrison Street, San Francisco, CA 94107, founded in 2018 with 300+ employees.


Smart electrical panels for homes


Fundraising Details


  • Amount Raised: $231M
  • Round Type: Series C
  • Valuation: $1B
  • Date: 2024-04-24
  • Investors: 5335 Capital, Capricorn Investment Group, Montage Ventures, BlackRock

About Span


Smart electrical panels for homes The company is positioned in the Home Energy sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 645 Harrison Street, San Francisco, CA 94107
  • Founded: 2018
  • Team Size: 300+
  • Industry: Home Energy

What This Means


This funding round demonstrates strong investor confidence in Span's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Home Energy sector continues to attract significant investment as companies innovate to meet evolving market demands. Span's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1B valuation marks an important milestone for Span, positioning the company among notable players in the Home Energy industry.


Looking Ahead


With this new capital, Span is well-positioned to execute on its growth strategy and continue building innovative solutions in the Home Energy space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-04-24. For more information about Span, visit their headquarters at 645 Harrison Street, San Francisco, CA 94107.

Company Info

Headquarters
645 Harrison Street, San Francisco, CA 94107
Founded
2018
Team Size
300+

Topics

Fundraising(2912)Series C(300)Home EnergySpan

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free